One Year Follow-up of Functional Recovery in Neovascular AMD During Monthly Anti-VEGF Treatment – Corrected Proof

Purpose: To identify neurosensory recovery, testing different functional variables during monthly intravitreal standard anti–vascular endothelial growth factor (VEGF) therapy in neovascular age-related macular degeneration (AMD).Design: Prospective interventional cohort study.Methods: Sixty-four treatment-naïve neovascular AMD patients with subfoveal lesions were treated and examined monthly for distance visual acuity, reading acuity, maximum reading speed, and contrast sensitivity and with microperimetry evaluating the percentage of absolute and relative scotoma and mean central retinal sensitivity weighted by area. Improvements in reading acuity, distance acuity, reading speed, contrast sensitivity, mean central retinal sensitivity, and scotoma area in dependence of age, lesion type, lesion size, and mean (Read more...)

Full Story →